Loss of heterozygosity at 9q33 and hypermethylation of the DBCCR1 gene in oral squamous cell carcinoma

British Journal of Cancer

Volumn 91, Issue 4, 2004, Pages 760-764

  Gao, S ^a   Worm, J ^b   Guldberg, P ^b   Eiberg, H ^c   Krogdahl, A ^d   Sorensen J A ^d   Liu, C J ^e   Reibel, J ^a   Dabelsteen, E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chromosome 9q; DBCCR1; DNA methylation; Loss of heterozygosity; Oral carcinoma

Indexed keywords

ARTICLE; CHROMOSOME 9Q; CONTROLLED STUDY; DNA DETERMINATION; DYSPLASIA; EPITHELIUM CELL; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LEUKOPLAKIA; MELTING POINT; METHYLATION; MOUTH CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SQUAMOUS CELL CARCINOMA;

EID: 4344643651     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601980     Document Type: Article

References (28)

1. Ah-See KW, Cooke TG, Pickford IR, Soutar D, Balmain A (1994) An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 54: 1617-1621
2. Akanuma D, Uzawa N, Yoshida MA, Negishi A, Amagasa T, Ikeuchi T (1999) Inactivation patterns of the p16 (INK4a) gene in oral squamous cell carcinoma cell lines. Oral Oncol 35: 476-483
3. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH (2003) A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63: 1727-1730
4. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D (1996) Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56: 2488-2492
5. Chang HW, Chow V, Lam KY, Wei WI, Yuen A (2002) Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer 94: 386-392
6. Clark SJ, Harrison J, Paul CL, Frommer M (1994) High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22: 2990-2997
7. Fujiwara H, Emi M, Nagai H, Ohgaki K, Imoto I, Akimoto M, Ogawa O, Habuchi T (2001) Definition of a 1-Mb homozygous deletion at 9q32-q33 in a human bladder-cancer cell line. J Hum Genet 46: 372-377
8. Gao S, Worm J, Guldberg P, Eiberg H, Krogdahl A, Liu CJ, Reibel J, Dabelsteen E (2004) Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int J Cancer 109: 230-237
9. Habuchi T, Luscombe M, Elder PA, Knowles MA (1998) Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. Genomics 48: 277-288
10. Habuchi T, Takahashi T, Kakinuma H, Wang L, Tsuchiya N, Satoh S, Akao T, Sato K, Ogawa O, Knowles MA, Kato T (2001) Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer. Oncogene 20: 531-537
11. Habuchi T, Yoshida O, Knowles MA (1997) A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC. Hum Mol Genet 6: 913-919
12. Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT (2002) Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene 21: 4231-4236
13. Kim HS, Chung WB, Hong SH, Kim JA, Na SY, Jang HJ, Sohn YK, Kim JW (2000) Inactivation of p16INK4a in primary tumors and cell lines of head and neck squamous cell carcinoma. Mol Cells 10: 557-565
14. Kominato Y, Hata Y, Takizawa H, Tsuchiya T, Tsukada J, Yamamoto F (1999) Expression of human histo-blood group ABO genes is dependent upon DNA methylation of the promoter region. J Biol Chem 274: 37240-37250
15. Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics, 1999. CA Cancer J Clin 49: 8-311
16. Nephew KP, Huang TH (2003) Epigenetic gene silencing in cancer initiation and progression. Cancer Lett 190: 125-133
17. Nishiyama H, Gill JH, Pitt E, Kennedy W, Knowles MA (2001) Negative regulation of G(1)/S transition by the candidate bladder tumour suppressor gene DBCCR1. Oncogene 20: 2956-2964
18. Nishiyama H, Takahashi T, Kakehi Y, Habuchi T, Knowles MA (1999) Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer. Genes Chromosomes Cancer 26: 171-175
19. Ogi K, Toyota M, Ohe-Toyota M, Tanaka N, Noguchi M, Sonoda T, Kohama G, Tokino T (2002) Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin Cancer Res 8: 3164-3171
20. Partridge M, Emilion G, Pateromichelakis S, Phillips E, Langdon J (1999) Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas. Int J Cancer 83: 318-325
21. Silverman Jr S (2001) Demographics and occurrence of oral and pharyngeal cancers, the outcomes, the trends, the challenge. J Am Dent Assoc 132(Suppl): 7S-11S
22. Viswanathan M, Tsuchida N, Shanmugam G (2003) Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer 105: 41-46
23. Warnakulasuriya S (2000) Lack of molecular markers to predict malignant potential of oral precancer. J Pathol 190: 407-409
24. Warnakulasuriya S (2001) Histological grading of oral epithelial dysplasia: revisited. J Pathol 194: 294-297
25. Williams HK (2000) Molecular pathogenesis of oral squamous carcinoma. Mol Pathol 53: 165-172
26. Worm J, Aggerholm A, Guldberg P (2001) In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin Chem 47: 1183-1189
27. Worm J, Guldberg P (2002) DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy. J Oral Pathol Med 31: 443-449
28. Yakushiji T, Noma H, Shibahara T, Arai K, Yamamoto N, Tanaka C, Uzawa K, Tanzawa H (2001) Analysis of a role for p16/CDKN2 expression and methylation patterns in human oral squamous cell carcinoma. Bull Tokyo Dent Coll 42: 159-168